Nuclear Medicine

SSB/Transregio with Heidelberg University in preparation – “BRIGHT LIGHT for actinide research” - Nuclear Medicine in focus:

Development of labeled radiopharmaceuticals for targeted alpha therapy of tumors using alpha-emitting radionuclides;  

Development and applications of novel experimental and computational synchrotron based spectroscopic techniques to obtain predictive structure – function relationships of labeled radiopharmaceuticals;

Development of high energy resolution X- ray detectors based on Metallic Magnetic Calorimeters (MMC) for advanced characterization of labeled radiopharmaceuticals;

Development of radionuclide generators for rare alpha-emitting radionuclides with high potential for alpha therapy of tumors.